NicOx

NicOx is a French biopharmaceutical company specializing in the development of nitric oxide (NO)-donating drugs for various indications. Its primary focus is on ophthalmology, with NCX 470 in clinical trials for lowering intraocular pressure in glaucoma patients. The company also has a preclinical program on NCX 1728 and has commercialized VYZULTA for glaucoma through an exclusive license to Bausch + Lomb.

Gavin Spencer

CEO

3 past transactions

Doliage

Acquisition in 2014
Doliage is a pharmaceutical company specializing in ophthalmic products, particularly focusing on conditions such as dry eye syndrome, glaucoma, and eye infections. Established in 2004, Doliage has been at the forefront of developing medical food supplements specifically tailored for ophthalmology. The company was the first to combine lutein and omega-3 in its formulations, setting a standard in micronutrition for eye health. In 2009, Doliage expanded its product line to include B vitamins, further enhancing its offerings in dietary supplements. All products are manufactured in a pharmaceutical environment, ensuring high quality and compliance with industry standards. Through its commitment to staying updated with the latest scientific research, Doliage maintains a comprehensive portfolio of dietary supplements and prescription pharmaceuticals, including Euronac for corneal healing and Tobrabact Ge, an ocular antibiotic.

Aciex Therapeutics

Acquisition in 2014
Aciex is focused on developing first-in-class products to fill unmet needs for ophthalmic therapeutics—products that will permit us to build a sustainable ophthalmic franchise. They believe their company is unique in both concept and products and timely in terms of the market, and they are pleased you have chosen to learn more about Aciex.

EuPharmed

Acquisition in 2013
EuPharmed s.r.l. is an Italian pharmaceutical company specializing in the development and marketing of various healthcare products, with a particular focus on the ophthalmological sector. The company's portfolio includes pharmaceutical products, over-the-counter items, parapharmaceuticals, nutraceuticals, and medical devices designed to treat a range of ocular pathologies and ophthalmic diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.